Killer Ig-like receptor-mediated control of natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation
出版年份 2010 全文链接
标题
Killer Ig-like receptor-mediated control of natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation
作者
关键词
-
出版物
BLOOD
Volume 117, Issue 3, Pages 764-771
出版商
American Society of Hematology
发表日期
2010-10-02
DOI
10.1182/blood-2010-08-264085
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A novel KIR-associated function: evidence that CpG DNA uptake and shuttling to early endosomes is mediated by KIR3DL2
- (2010) S. Sivori et al. BLOOD
- NK cells mediate reduction of GVHD by inhibiting activated, alloreactive T cells while retaining GVT effects
- (2010) J. A. Olson et al. BLOOD
- NKAML: A Pilot Study to Determine the Safety and Feasibility of Haploidentical Natural Killer Cell Transplantation in Childhood Acute Myeloid Leukemia
- (2010) Jeffrey E. Rubnitz et al. JOURNAL OF CLINICAL ONCOLOGY
- Combined Genotypic and Phenotypic Killer Cell Ig-Like Receptor Analyses Reveal KIR2DL3 Alleles Displaying Unexpected Monoclonal Antibody Reactivity: Identification of the Amino Acid Residues Critical for Staining
- (2010) M. Falco et al. JOURNAL OF IMMUNOLOGY
- Crosstalk between decidual NK and CD14+ myelomonocytic cells results in induction of Tregs and immunosuppression
- (2010) P. Vacca et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Uptake of CCR7 and acquisition of migratory properties by human KIR+ NK cells interacting with monocyte-derived DC or EBV cell lines: regulation by KIR/HLA-class I interaction
- (2009) E. Marcenaro et al. BLOOD
- Preclinical characterization of 1-7F9, a novel human anti-KIR receptor therapeutic antibody that augments natural killer-mediated killing of tumor cells
- (2009) F. Romagne et al. BLOOD
- Education of human natural killer cells by activating killer cell immunoglobulin-like receptors
- (2009) C. Fauriat et al. BLOOD
- Haploidentical hemopoietic stem cell transplantation for the treatment of high-risk leukemias: How NK cells make the difference
- (2009) Franco Locatelli et al. CLINICAL IMMUNOLOGY
- KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A*11 while diminishing avidity for HLA-C
- (2009) Thorsten Graef et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans
- (2009) Cameron S. Brandt et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Temporal, quantitative, and functional characteristics of single-KIR-positive alloreactive natural killer cell recovery account for impaired graft-versus-leukemia activity after haploidentical hematopoietic stem cell transplantation
- (2008) L. Vago et al. BLOOD
- Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity
- (2008) D. Pende et al. BLOOD
- A survey of fully haploidentical hematopoietic stem cell transplantation in adults with high-risk acute leukemia: a risk factor analysis of outcomes for patients in remission at transplantation
- (2008) F. Ciceri et al. BLOOD
- Human NK cells: from HLA class I-specific killer Ig-like receptors to the therapy of acute leukemias
- (2008) Alessandro Moretta et al. IMMUNOLOGICAL REVIEWS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now